Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Area of Science:

• Infectious Diseases
• Computational Chemistry
• Drug Discovery

Background:

• Rising incidence of drug-sensitive and drug-resistant Mycobacterium tuberculosis strains.
• Limited development of new tuberculosis drugs in over four decades.
• Need for innovative strategies to address the global TB crisis.

Purpose of the Study:

• To review the role of cheminformatic techniques in tuberculosis drug discovery.
• To propose optimal integration of computational and experimental approaches.
• To accelerate the identification of new anti-TB drug candidates.

Main Methods:

• Examination of cheminformatic techniques applied to TB drug discovery.
• Analysis of data generated from high-throughput screening efforts.
• Literature review of computational approaches in drug development.

Main Results:

• Cheminformatics offers a complementary approach to high-throughput screening.
• Computational methods can aid in progressing from initial hits to clinical candidates.
• Successful drug discovery requires a synergistic workflow.

Conclusions:

• Integrating computational and experimental methods is crucial for accelerating TB drug discovery.
• Optimizing the use of screening data through cheminformatics is essential.
• Novel computational strategies can overcome challenges in developing new TB therapeutics.